Cover image of the article: Stage I seminoma recurrences in patients admitted to radiotherapy clinic of Shohada hospital between 1991 and 2002

Image Credit:Int J Cancer Manag

Stage I seminoma recurrences in patients admitted to radiotherapy clinic of Shohada hospital between 1991 and 2002

Authors

B Mofid1, HR Mirzaei1, Afshin Rakhsha1,*
1Assisstant professor, Department of Radiation Oncology, Shahid Beheshti University (MC), Shohada Hospital; Cancer Research Center, Shahid Beheshti University (MC), Iran
*Corresponding Author: Corresponding author: Afshin Rakhsha, Assisstant professor, Department of Radiation Oncology, Shahid Beheshti University (MC), Shohada Hospital; Cancer Research Center, Shahid Beheshti University (MC), Iran, Tel: +98-21-22718081, Fax: +98-21-22718082, E-mail: Email: rakhsha@journal.com

International Journal of Cancer Management:Vol. 1, issue 2; e80414
Published online:Apr 30, 2008
Article type:Research Article
Received:Apr 30, 2008
Accepted:Apr 30, 2008
How to Cite:Mofid B, Mirzaei H, Rakhsha A. Stage I seminoma recurrences in patients admitted to radiotherapy clinic of Shohada hospital between 1991 and 2002. Int J Cancer Manag. 2008;1(2):e80414. doi:

Abstract

Introduction: Currently, cancers are among the important and main problems of health system in Iran and around the world. In young men under 20 to 35 years of age, malignant masses of testis are the most common tumours. The main pathologic feature of these masses is germ cell tumour and about half of them are seminoma. Since seminoma is very prevalent in the forth decade, being affected with this tumour leads to losing many years of healthy life. Method: In a cross sectional study, investigating 139 records of patients with testis tumour revealed 61 patients with stage-1 seminoma. Thirty three patients underwent para-aortic and unilateral pelvic irradiation (54%) while 28 patients only underwent para-aortic irradiation (46%). The administered radiotherapy dosage varied between 25-40 Gy. Results: Mean age of the patients was 37.8 of whom the youngest was 15 and the oldest was 64 years of age. Only one recurrent patient was seen in this cohort who was in para-aortic group. There was no significant difference in recurrence rate between the two radiotherapy methods. (p= 0.7). Conclusion: Considering fewer complications of para-aortic irradiation and the insignificant difference in the recurrence rate between the two methods of radiotherapy, para-aortic method could be more appropriate and acceptable in the treatment of testicular cancer

Highlights

Fulltext

Full text is available in PDF.
 

Copyright

© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

3
May
2017
Clinicopathology Illustration Treatment Options and Survival in the Patients with Testicular Germ Cell Tumors in Kermanshah Province, Iran

Clinicopathology Illustration Treatment Options and Survival in the Patients with Testicular Germ Cell Tumors in Kermanshah Province, Iran

Mehrdad Payandeh,
Nasrin Amirifard,
Edris Sadeghi,
Masoud Sadeghi

Payandeh M, Amirifard N, Sadeghi E, Sadeghi M. Clinicopathology Illustration Treatment Options and Survival in the Patients with Testicular Germ Cell Tumors in Kermanshah Province, Iran. Int J Cancer Manag. 2017;10(5):e4039. doi: https://doi.org/10.5812/ijcm.4039

16
Sep
2015
Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences

Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences

Mohamadreza Nowroozi,
Mohsen Ayati,
Amir Arbab,
Hassan Jamshidian,
Hamidreza Ghorbani,
Hassan Niroomand
,et al.

Nowroozi M, Ayati M, Arbab A, Jamshidian H, Ghorbani H, et al. Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences. Nephro-Urol Mon. 2015;7(5):e27343. doi: https://doi.org/10.5812/numonthly.27343

25
Jul
2014
Pediatric Germ Cell Tumors; A 10-year Experience

Pediatric Germ Cell Tumors; A 10-year Experience

Ahmad Khaleghnejad-Tabari,
Alireza Mirshemirani,
Mohsen Rouzrokh,
Leily Mohajerzadeh,
Nasibeh Khaleghnejad-Tabari,
shaghayegh Hasas-Yeganeh

Khaleghnejad-Tabari A, Mirshemirani A, Rouzrokh M, Mohajerzadeh L, Khaleghnejad-Tabari N, et al. Pediatric Germ Cell Tumors; A 10-year Experience. Inn J Pediatr. 2014;24(4):. doi:

1
Jul
2025
Investigating the Incidence of Contralateral Metachronous Testicular Cancer Following Radical Orchidectomy

Investigating the Incidence of Contralateral Metachronous Testicular Cancer Following Radical Orchidectomy

Navid Masoumi,
Alireza Hatami

Masoumi N, Hatami A. Investigating the Incidence of Contralateral Metachronous Testicular Cancer Following Radical Orchidectomy. Int J Cancer Manag. 2025;18(1):e161849. doi: https://doi.org/10.5812/ijcm-161849

24
Aug
2015
Germ Cell Tumor’s Survival Rate in Young Patients

Germ Cell Tumor’s Survival Rate in Young Patients

Nafiseh Mortazavi,
Parvin Mahzooni,
Diana Taheri,
Mahshid Jalilian,
Kambiz Novin

Mortazavi N, Mahzooni P, Taheri D, Jalilian M, Novin K. Germ Cell Tumor’s Survival Rate in Young Patients. Int J Cancer Manag. 2015;8(4):e3440. doi: https://doi.org/10.17795/ijcp.3440

More by these authors

HR MirzaeiPubMedScholar
Afshin RakhshaPubMedScholar
Share
Cited by
Metrics